A randomized pharmacokinetic-pharmacodynamic evaluation of the potential biosimilar interferon beta-1a product, CinnoVex®.

Mika Scheinin,Zsófia Lovró,Inger-Helen Maadik,Jaana Suopanki-Lalowski,Seyed Hossein Seyedagha,Morteza Azhdarzadeh

A randomized pharmacokinetic-pharmacodynamic evaluation of the potential biosimilar interferon beta-1a product, CinnoVex®.

2021

Mika Scheinin
Zsófia Lovró
Inger-Helen Maadik
Jaana Suopanki-Lalowski
Seyed Hossein Seyedagha
Morteza Azhdarzadeh

Background: The objective of the trial was to evaluate the bioequivalence of the interferon beta-1a (IFN beta-1a) biosimilar product candidate CinnoVex® with the reference product Avonex® by compar...

Keywords:

Biosimilar
Pharmacodynamics
Interferon beta-1a
reference product
pharmacokinetic pharmacodynamic
Pharmacology
Bioequivalence
Interferon
Medicine
Pharmacokinetics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations